Trusted Resources: Education
Scientific literature and patient education texts
Difficulties Associated With Enzyme Replacement Therapy for Mucopolysaccharidoses
source: Turkish archives of pediatrics
year: 2021
authors: Yıldız Y,Sivri HS
summary/abstract:Mucopolysaccharidoses are extremely rare, progressive, often severe multisystem disorders, some of which are managed by weekly intravenous enzyme replacement therapy. This study aimed to determine the difficulties faced by the patients with mucopolysaccharidosis and their families due to enzyme replacement therapy.
organization: Division of Pediatric Metabolism, Department of Pediatrics, Hacettepe University School of Medicine, Ankara, Turkey.DOI: 10.5152/TurkArchPediatr.2021.21235
read more
BookmarkRelated Content
-
[Pharmacological Property, Mechanism of Action and Clinical Study Results of Pabinafusp Alfa (Genetical Recombinatio...Mucopolysaccharidosis type II (MPS II) i...
-
Long-Term Evolution of Mucopolysaccharidosis Type I in Twins Treated With Enzyme Replacement Therapy Plus Hematopoie...Mucopolysaccharidoses (MPSs) are a heter...
-
Advances in Approaches to Care and Monitoring of MPS Diseasehttps://www.youtube.com/watch?v=JZSVzeiX...
-
Progression of Cardiovascular Manifestations in Adults and Children With Mucopolysaccharidoses With and Without Enzy...Cardiovascular involvement is among the ...
-
Expanding the Phenotype of Mucopolysaccharidosis Type II RetinopathyPurpose: To report novel retinal finding...
-
The Impact of Excluding Nonrandomized Studies From Systematic Reviews in Rare Diseases: “The Example of Meta-A...Nonrandomized studies are usually exclud...
-
Elosulfase Alfa in the Treatment of Mucopolysaccharidosis Type IVA: Insights From the First Managed Access AgreementManaged access agreements provide a cruc...
Powered by
